CLINICAL "M"
|
|
|
Fig.
61: Cumulative
proportion of patients
with non-small cell lung
cancer expected to survive
5 years after treatment
according to clinical "M" status.
M0, n=3,443; M1, n=1,166,
P <0.05. |
|
|
The presence or absence of distant metastasis
is the most decisive factor for treatment
selection and prognosis. |